Medial Epicondylitis When Surgical or Procedural Debridement Did Not Restore Full Activity
Some patients with medial epicondylitis do not achieve the expected return to full, unrestricted activity following operative or procedural management. This page describes the next-line approach evaluated for that refractory situation.
Prior treatment — failure condition
The preceding protocol involved surgical or procedural debridement of the flexor-pronator group — including open debridement with reattachment, elbow arthroscopy with debridement and decortication, or percutaneous ultrasound-guided treatment. The trigger for escalation is failure to return to full, unrestricted activity within the expected 3–4 month postoperative window.
Next-line approach — partial overview
Novel interventions are available for this refractory presentation. The protocol involves a specialised injection-based or endovascular technique — the specific agents, sequence, and eligibility criteria are part of the full structured regimen.
Full protocol details, including selection criteria and procedural specifics, are available via the link below.
Clinical targets
The primary goals are meaningful improvement in pain (Visual Analog Pain Scale) and elbow function (Mayo Elbow Performance Score) sustained up to one year after the intervention.
References
DOI: 10.1016/j.jorep.2023.100172
- Novel interventions for refractory ME treatment include injections of neutrophil-reduced platelet-rich plasma, and transcatheter arterial embolization.
- Although not widely available, this is typically performed with imipenem and microspheres.
- Recent studies showed significantly improved Visual Analog Pain Scale (VAS) and Mayo Elbow Performance Scores (MEPS) up to one year after PRP injection; however, this is less effective in cases with complete tears.
View source ↗